Methodologies for Health Risk Assessment of Mutagenic Impurities in Medications and the Role of Pharmacoepidemiology
Journal of Pharmacoepidemiology and Risk Management · 2021
DOI: 10.56142/2021.13.1.10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacoepidemiology and Risk Management, 2021. Verfasst von Ye-Jin Kang und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Ye-Jin Kang,BS, Myo-Song Kim,MS, Min-Taek Lee,MS, Seung-Hun You,MS, Jae-Eun Lee,BPharm, Joo-Hyeon Eom,BS and Sun-Young Jung, PhD. Journal of Pharmacoepidemiology and Risk Management 2021;13:10-6. https://doi.org/10.56142/2021.13.1.10
Zitieren
APA
Kang, Y., Kim, M., Lee, M., You, S., Lee, J., Eom, J., & Jung, S. (2021). Methodologies for Health Risk Assessment of Mutagenic Impurities in Medications and the Role of Pharmacoepidemiology. Journal of Pharmacoepidemiology and Risk Management. https://doi.org/10.56142/2021.13.1.10
Vancouver
Kang Y, Kim M, Lee M, You S, Lee J, Eom J, et al. Methodologies for Health Risk Assessment of Mutagenic Impurities in Medications and the Role of Pharmacoepidemiology. Journal of Pharmacoepidemiology and Risk Management. 2021. doi:10.56142/2021.13.1.10
BibTeX
@article{Kang2021,
author = {Kang, Ye-Jin and Kim, Myo-Song and Lee, Min-Taek and You, Seung-Hun and Lee, Jae-Eun and Eom, Joo-Hyeon and Jung, Sun-Young},
title = {Methodologies for Health Risk Assessment of Mutagenic Impurities in Medications and the Role of Pharmacoepidemiology},
journal = {Journal of Pharmacoepidemiology and Risk Management},
year = {2021},
doi = {10.56142/2021.13.1.10}
}
EUVIMED